AlphaMark Advisors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,725
| Closed | -$314K | – | 678 |
|
|
2024
Q3 | $314K | Sell |
1,725
-197
| -10% | -$35.9K | 0.11% | 183 |
|
|
2024
Q2 | $353K | Buy |
+1,922
| New | +$353K | 0.12% | 108 |
|
|
2022
Q4 | – | Sell |
-10
| Closed | -$1K | – | 657 |
|
|
2022
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 641 |
|
|
2022
Q2 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 590 |
|